GEODE CAPITAL MANAGEMENT, LLC - ALDER BIOPHARMACEUTICALS INC ownership

ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 130 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 7.84 and the average weighting 0.2%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$18,293,000
+64.6%
969,950
+2.7%
0.00%
+33.3%
Q2 2019$11,114,000
-6.2%
944,344
+8.8%
0.00%0.0%
Q1 2019$11,850,000
-10.8%
868,135
-33.1%
0.00%
+50.0%
Q4 2018$13,292,000
+28.9%
1,296,880
+109.5%
0.00%
-33.3%
Q3 2018$10,308,000
+9.4%
619,144
+3.9%
0.00%0.0%
Q2 2018$9,418,000
+29.9%
596,126
+4.4%
0.00%
+50.0%
Q1 2018$7,249,000
+13.1%
570,789
+2.0%
0.00%0.0%
Q4 2017$6,410,000
+1.4%
559,850
+8.5%
0.00%0.0%
Q3 2017$6,320,000
+32.4%
515,986
+23.8%
0.00%0.0%
Q2 2017$4,773,000
-42.9%
416,893
+3.8%
0.00%
-33.3%
Q1 2017$8,352,000
+21.4%
401,570
+21.4%
0.00%0.0%
Q4 2016$6,882,000
-35.7%
330,879
+1.3%
0.00%
-40.0%
Q3 2016$10,706,000
+31.3%
326,726
+0.1%
0.01%
+25.0%
Q2 2016$8,152,000
+85.7%
326,473
+82.1%
0.00%
+100.0%
Q1 2016$4,389,000
-24.3%
179,237
+2.1%
0.00%
-33.3%
Q4 2015$5,800,000
-4.3%
175,616
-5.1%
0.00%
-25.0%
Q3 2015$6,061,000
-6.9%
185,041
+50.6%
0.00%0.0%
Q2 2015$6,509,000
+109.0%
122,897
+13.9%
0.00%
+100.0%
Q1 2015$3,114,000
+103.1%
107,911
+104.7%
0.00%
+100.0%
Q4 2014$1,533,000
+211.0%
52,727
+35.4%
0.00%
Q3 2014$493,000
-36.6%
38,942
+0.5%
0.00%
-100.0%
Q2 2014$777,00038,7480.00%
Other shareholders
ALDER BIOPHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 1,628,328$33,869,00014.72%
Foresite Capital Management II, LLC 995,396$20,704,00010.39%
Cormorant Asset Management, LP 1,581,604$32,897,0004.43%
DAFNA Capital Management LLC 221,013$4,597,0004.04%
New Leaf Venture Partners, L.L.C. 228,428$4,751,0003.40%
Partner Investment Management, L.P. 63,571$1,322,0001.75%
Iguana Healthcare Management, LLC 140,000$2,912,0001.74%
PFM Health Sciences, LP 2,913,951$60,610,0001.71%
Redmile Group, LLC 920,550$19,147,0001.65%
SECTORAL ASSET MANAGEMENT INC 669,351$13,923,0001.54%
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders